Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenetic Biosciences (XBIO) Return on Equity (2023 - 2025)

Xenetic Biosciences' Return on Equity history spans 6 years, with the latest figure at 0.5% for Q4 2025.

  • For Q4 2025, Return on Equity rose 15.0% year-over-year to 0.5%; the TTM value through Dec 2025 reached 0.5%, up 15.0%, while the annual FY2025 figure was 0.42%, 11.0% up from the prior year.
  • Return on Equity reached 0.5% in Q4 2025 per XBIO's latest filing, up from 0.79% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.44% in Q4 2023 to a low of 0.81% in Q1 2023.
  • Average Return on Equity over 3 years is 0.63%, with a median of 0.63% recorded in 2024.
  • The largest YoY upside for Return on Equity was 29bps in 2024 against a maximum downside of -21bps in 2024.
  • A 3-year view of Return on Equity shows it stood at 0.44% in 2023, then plummeted by -48bps to 0.64% in 2024, then rose by 23bps to 0.5% in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Return on Equity are 0.5% (Q4 2025), 0.79% (Q3 2025), and 0.68% (Q2 2025).